This is an old revision of the document!
Objectives
Determine biomarkers for Alzheimer's and other neurodegenerative diseases using comprehensive analysis of various data including genomics, epigenomics, metabolomics, proteomics, etc.
Phase 1: Network analysis on proteome data of Fremingham cohort